[go: up one dir, main page]

GB0908425D0 - Medical use - Google Patents

Medical use

Info

Publication number
GB0908425D0
GB0908425D0 GBGB0908425.2A GB0908425A GB0908425D0 GB 0908425 D0 GB0908425 D0 GB 0908425D0 GB 0908425 A GB0908425 A GB 0908425A GB 0908425 D0 GB0908425 D0 GB 0908425D0
Authority
GB
United Kingdom
Prior art keywords
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0908425.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB0908425.2A priority Critical patent/GB0908425D0/en
Publication of GB0908425D0 publication Critical patent/GB0908425D0/en
Priority to PCT/GB2010/000969 priority patent/WO2010131009A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB0908425.2A 2009-05-15 2009-05-15 Medical use Ceased GB0908425D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0908425.2A GB0908425D0 (en) 2009-05-15 2009-05-15 Medical use
PCT/GB2010/000969 WO2010131009A2 (fr) 2009-05-15 2010-05-13 Traitement de maladies à médiation par il-25 par des antagonistes de tlr

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0908425.2A GB0908425D0 (en) 2009-05-15 2009-05-15 Medical use

Publications (1)

Publication Number Publication Date
GB0908425D0 true GB0908425D0 (en) 2009-06-24

Family

ID=40834096

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0908425.2A Ceased GB0908425D0 (en) 2009-05-15 2009-05-15 Medical use

Country Status (2)

Country Link
GB (1) GB0908425D0 (fr)
WO (1) WO2010131009A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2805989A1 (fr) * 2010-07-19 2012-01-26 Yeda Research And Development Co. Ltd. Peptides derives du domaine transmembranaire d'un recepteur de type toll (tlr) pour le traitement de maladies declenchees par les tlr
AU2012223366B2 (en) * 2011-03-03 2017-02-23 Quark Pharmaceuticals, Inc. Oligonucleotide modulators of the toll-like receptor pathway
SG192961A1 (en) 2011-03-03 2013-09-30 Quark Pharmaceuticals Inc Compositions and methods for treating lung disease and injury
CN103792375B (zh) * 2014-01-29 2017-07-07 华中科技大学同济医学院附属同济医院 外周血白细胞介素25水平在哮喘分型中的应用及分型方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5071972A (en) 1986-01-31 1991-12-10 Genetics Institute, Inc. DNA sequences encoding novel thrombolytic proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0276846A3 (fr) 1987-01-29 1989-07-26 Zymogenetics, Inc. Dérivés du facteur stimulant des colonies
IL103059A0 (en) 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
EP0672142B1 (fr) 1992-12-04 2001-02-28 Medical Research Council Proteines de liaison multivalentes et multispecifiques, leur fabrication et leur utilisation
GB9809951D0 (en) 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card

Also Published As

Publication number Publication date
WO2010131009A2 (fr) 2010-11-18
WO2010131009A3 (fr) 2011-01-06

Similar Documents

Publication Publication Date Title
CA3287327A1 (en) Extended Use Medical Device
GB0919432D0 (en) Use
EP2471437A4 (fr) Dispositif médical
EP2415386A4 (fr) Endoscope
EP2499034A4 (fr) Fauteuil roulant
EP2481355A4 (fr) Dispositif médical
GB2475364B (en) Endoscope
EP2478927A4 (fr) Cathéter
EP2515972A4 (fr) Dispositif médical
GB0922505D0 (en) Use
GB2469839B (en) Medical instrument
GB0921060D0 (en) Catheter
GB0908425D0 (en) Medical use
GB0915319D0 (en) Combination medicament
GB201012099D0 (en) Catheter
GB0917304D0 (en) Use
EP2385855A4 (fr) Sonde
GB0922316D0 (en) Syringe
GB0922098D0 (en) Therapeutic use
GB0914115D0 (en) Single use medical device
GB0920881D0 (en) Medical device
GB0900567D0 (en) Medical device
GB0901610D0 (en) Medical device
PH32009000305S1 (en) Tissue
HU0900041D0 (en) Crinoline

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)